Product regulatory status
Authorization, application, import and permitted-use status must be confirmed for the exact product and presentation in the target jurisdiction.
Global market pathways
Worldwide inquiry access. Jurisdiction-specific review.
METRYVA CARE accepts inquiries from every country and territory. Each proposed activity is assessed against the product status, responsible entities, quality requirements and permitted communications of the jurisdiction in which it would occur.
Global intake
Selected market briefs are reference guides, not geographic limits.
Use the global selector for any country or territory. Selected markets also have dedicated pages with regulator links and preliminary program boundaries.
Worldwide inquiries
Select the country or territory for your inquiry.
This allows us to consider the applicable product status and local requirements. It does not indicate product approval or availability.
Featured market briefs
Detailed reference pages for selected jurisdictions.
These summaries support preliminary orientation only. Current official requirements and product-specific status must be independently verified before activity begins.
North America
United States
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- FDA and state boards of pharmacy
- Current scope
- Qualified counterparties under evaluation
- Selected cities
- Miami · Houston · Dallas + more
North America
Canada
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- Health Canada and provincial or territorial regulators
- Current scope
- Province-specific pathway assessment
- Selected cities
- Toronto · Vancouver · Montreal + more
Latin America
Brazil
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- ANVISA
- Current scope
- Local regulatory and partner assessment
- Selected cities
- São Paulo · Rio de Janeiro · Belo Horizonte + more
Latin America
Mexico
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- COFEPRIS
- Current scope
- Local regulatory and partner assessment
- Selected cities
- Mexico City · Monterrey · Guadalajara + more
Latin America
Argentina
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- ANMAT
- Current scope
- Local regulatory and partner assessment
- Selected cities
- Buenos Aires · Córdoba · Rosario + more
Latin America
Paraguay
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- DINAVISA
- Current scope
- Importer and registration pathway assessment
- Selected cities
- Asunción · San Lorenzo · Ciudad del Este + more
Latin America
Chile
Preliminary regulatory, product-status and counterparty pathway overview.
- Regulatory reference
- Instituto de Salud Pública de Chile
- Current scope
- Local regulatory and partner assessment
- Selected cities
- Santiago · Viña del Mar · Concepción + more
Market assessment
Core conditions for a credible local pathway.
Authorized local entities
Registration, import, release, distribution, professional care and dispensing functions must be assigned to entities permitted to perform them.
Quality and supply capability
Storage, transport, temperature control, traceability, complaint handling, recalls and post-market processes must match the product and pathway.
Permitted communications
Public information, professional education, labeling and promotional claims must reflect the applicable product status and local audience rules.
Global inquiry
Select a market and submit your requirement.
Individuals may request general product information. Qualified organizations may submit a commercial or institutional inquiry for any country or territory.